Market Access Blogs August 28, 2024 Industry Updates, Biosimilar Barriers, and & the Impact of IRA Medicare... 6 Minute Read Read the latest on Industry Updates, Biosimilar Barriers, and the Impact of Drug Price Negotiations.
Market Access Blogs July 29, 2024 The 340B Saga, New Orphan Drug Exclusion Criteria & Drug Shortages... 4 Minute Read Read the latest on IRA implications on rare disease, economic challenges underpinning drug shortages, and navigating the 340B saga.
Market Access Blogs June 28, 2024 States Influence Drug Pricing and Access, Specialty Pharmacies Evolve to Accommodate... 4 Minute Read Read the latest on how states influence drug pricing and access, specialty pharmacies evolution to supoprt cell & gene therapies, and Walgreens entering the CGT arena.
Market Access Blogs May 30, 2024 IRA Part D Redesign, New Gene Therapies Give Hope for Patients,... 5 Minute Read Discover the latest on IRA Part D Redesign Financial Implications, New Gene Therapies Give Newfound Hope for Patients, and Impact of Credit Card Fees in Government Pricing.
Launch Readiness March 21, 2023 Perspectives on Pharma Market Access Launch Challenges & Strategy Part 2 9 Minute Read We asked three market access leaders with significant launch experience across varying therapeutic categories about their launch journey–from pre-launch strategy and planning to post-launch optimization.
Launch Readiness February 7, 2023 Perspectives on Pharma Market Access Launch Challenges & Strategy Part 1 5 Minute Read We asked three market access leaders with significant launch experience across varying therapeutic categories about their launch journey–from pre-launch strategy and planning to post-launch optimization.
Market Access Blogs April 19, 2022 The Top 10 Market Access Challenges 5 Minute Read We explore the 10 most common challenges facing Market Access operations, based on over 15 years of experience with more than 250 pharma manufacturers.
Market Access Blogs February 28, 2022 Overcoming Drug Commercialization Challenges in Rare Disease 5 Minute Read Solutions to common challenges that manufacturers face when commercializing rare and orphan disease therapies.
Launch Readiness January 19, 2022 Best Practices: Redesigning the Perfect Launch 3 Minute Read We ask market access leaders what they would change if they had the ability to launch their therapy all over again.
